BFS
RIGL icon

Bare Financial Services’s Rigel Pharmaceuticals RIGL Stock Holding History

Bare Financial Services’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665 Buy
17
+6
+55% +$185 ﹤0.01% 1549
2026
Q1 		$297 Buy
+11
New +$370 ﹤0.01% 1711

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bare Financial Services's RIGL Position: Q2 2026 in Review

Bare Financial Services increased its Rigel Pharmaceuticals (RIGL) stake by 55% in Q2 2026, buying an estimated $185 and bringing the position to 17 shares worth $665. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Bare Financial Services first reported a position in RIGL in Q1 2026 and has held it in 2 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Bare Financial Services held 17 shares of Rigel Pharmaceuticals worth $665 as of Q2 2026.
  • Bare Financial Services bought 6 Rigel Pharmaceuticals shares in Q2 2026, an estimated $185.
  • Rigel Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1549 holding.
  • Bare Financial Services first reported a position in Rigel Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.